Joshua V.
Ruppel
ab,
Xin
Cui
a,
Xue
Xu
a and
X. Peter
Zhang
*a
aDepartment of Chemistry, University of South Florida, Tampa, Florida 33620-5250, USA. E-mail: xpzhang@usf.edu
bDivision of Natural Sciences and Engineering, University of South Carolina Upstate, Spartanburg, South Carolina 29303, USA
First published on 15th April 2014
Co(II) complexes of D2-symmetric chiral porphyrins have been proven to be effective metalloradical catalysts for the asymmetric intramolecular cyclopropanation of allyl α-diazoacetates. 4-(Dimethylamino)pyridine (DMAP), through a positive trans effect, plays an important role in the enhancement of the asymmetric induction for the intramolecular cyclopropanation process. This metalloradical catalytic system is suitable for cyclopropanation of allyl α-diazoacetates with varied functional groups and substitution patterns, producing bicyclic products with complete diastereocontrol and good enantiocontrol.
As stable metalloradicals with a well-defined open-shell doublet d7 electronic structure, cobalt(II) complexes of porphyrins [Co(Por)] have been demonstrated as a new class of potent metalloradical catalysts for cyclopropanation reactions.6 The unprecedented radical pathway initiated by this new system enabled the development of highly asymmetric cyclopropanation of a broad combination of olefin substrates and diazo reagents.7 Recently, Co(II) complexes of D2-symmetric chiral porphyrins [Co(D2-Por*)] were reported to be effective catalysts for the asymmetric intramolecular cyclopropanation of allyl α-diazoacetates with two electron-withdrawing α-groups, namely acceptor/acceptor-substituted diazo reagents.8 While the Co(II)-catalyzed intramolecular cyclopropanation was shown to be both general and highly stereoselective for various acceptor/acceptor-substituted diazo reagents, only one example of acceptor-substituted allyl α-diazoacetate was examined with the catalytic system for intramolecular formation of the corresponding bicyclo[3.1.0]hexan-2-one via the Co(II)-based metalloradical catalysis (MRC).9 To assess whether the Co(II)-based MRC would also be generally effective for acceptor-substituted diazo reagents, in addition to the well-demonstrated acceptor/acceptor-substituted diazo reagents, we have performed a systematic investigation on asymmetric intramolecular cyclopropanation of allyl α-diazoacetates.
The initial experiments were focused on the intramolecular cyclopropanation of cinnamyl α-diazoacetate (1a) (Table 1) by utilizing a standard “toolbox” of first-generation metalloradical catalysts [Co(P1–P6)] (Fig. 1), which have been proven to be effective for a variety of asymmetric intermolecular cyclopropanation reactions.7 Applying similar conditions that were optimized for asymmetric intermolecular olefin cyclopropanation with α-diazoacetates, which took the advantage of the positive trans effect of DMAP as an additive,11 it was found that the use of 2 mol % of [Co(P1)] (P1 = 3,5-DitBu-ChenPhyrin) could successfully catalyze the cyclopropanation reaction of 1a in 75% yield with complete diastereocontrol and significant asymmetric induction (entry 1). In the absence of DMAP, the enantioselectivity of the intramolecular cyclopropanation process dropped dramatically while the yield was substantially increased (entry 2). This result demonstrates that the additive DMAP, a potential axial ligand for the Co center, played an important role in enhancing the asymmetric induction for this catalytic intramolecular process. Under the same conditions, the catalyst [Co(P2)] (P2 = 2,6-DiMeO-ChenPhyrin), which contains the same chiral amide units as [Co(P1)] but with more sterically hindered non-chiral substituents, appeared to be similarly stereoselective, but less active (entry 3). [Co(P3–P6)] (Fig. 1) represent a subclass of [Co(D2-Por*)] catalysts with enhanced rigidity in a chiral environment due to the presence of an intramolecular hydrogen bond in the chiral amide unit. Among them, [Co(P6)] was reported to be an excellent catalyst for the asymmetric cyclopropanation of diazosulfones.7c These catalysts, however, were found to be ineffective for the intramolecular cyclopropanation of allyl α-diazoacetate 1a (entries 4–7).
Using the most active [Co(P1)] as the catalyst, the effect of solvents was then examined for the catalytic intramolecular cyclopropanation reaction of allyl α-diazoacetate 1a (Table 2). The metalloradical cyclopropanation could proceed in a variety of solvents, including coordinating and non-coordinating, aromatic and aliphatic, polar and non-polar as well as halogenated solvents (entries 2–6). The reactivity and stereoselectivity of the cyclopropanation reaction were generally unaffected by the broad range of solvent characteristics, except the non-polar hexanes which provided insufficient solubility. Among the solvents examined, DCM was selected as the solvent of choice as it provided the highest enantioselectivity while retaining a satisfactory yield. Additional experiments were attempted to fine-tune the reaction conditions by optimizing the additive stoichiometry and reaction temperature. It was shown that either decrease or increase in the amount of DMAP led to lower yields and slight decrease in the enantioselectivity (entries 7–9), indicating that 0.5 equivalent of DMAP is optimal for the intramolecular reaction, which is consistent with the reported intermolecular reactions.6a,11 Although lower and higher temperature resulted in increase of the enantioselectivity and yield, respectively (entries 10 and 11), room temperature was chosen to be optimal since it gave the best overall performance.
Entry | Additive (equiv.) | Solvent | Temp. | Yieldb (%) | eec (%) |
---|---|---|---|---|---|
a Reactions were carried out in a one-portion protocol using 2 mol % catalyst under N2 for 24 h with [1] = 0.20 M. The trans/cis ratio was determined by 1H NMR. b Isolated yields. c Enantiomeric excess of the major diastereomer was determined by chiral HPLC. | |||||
1 | DMAP (0.5) | MeCN | R.T. | 75 | 68 |
2 | DMAP (0.5) | Toluene | R.T. | 66 | 62 |
3 | DMAP (0.5) | PhCl | R.T. | 75 | 61 |
4 | DMAP (0.5) | DCM | R.T. | 70 | 72 |
5 | DMAP (0.5) | Hexanes | R.T. | 31 | 65 |
6 | DMAP (0.5) | EtOAc | R.T. | 74 | 64 |
7 | DMAP (0.5) | DCM | R.T. | 70 | 72 |
8 | DMAP (0.25) | DCM | R.T. | 57 | 68 |
9 | DMAP (0.75) | DCM | R.T. | 50 | 69 |
10 | DMAP (0.5) | DCM | 0 °C | 37 | 76 |
11 | DMAP (0.5) | DCM | 40 °C | 76 | 64 |
Under the optimized reaction conditions, the [Co(P1)]-based metalloradical intramolecular cyclopropanation system was found to be applicable for different allyl α-diazoacetates (Table 3). In addition to cinnamyl α-diazoacetate (1a) (entry 1), different (E)-3-aryl allyl α-diazoacetates with groups that possess different steric and electronic properties on the aromatic ring could also undergo smooth cyclopropanation reactions by [Co(P1)] to form the corresponding bicyclic products. For example, α-diazoacetates 1b and 1c with para- and ortho-methyl groups, respectively, could be converted to the bicyclic products 2b and 2c as single diastereomers in excellent yields with good enantioselectivities (entries 2 and 3). In addition, α-diazoacetate 1d containing an electron-donating MeO-group was shown to be a suitable substrate for the [Co(P1)]-catalyzed cyclopropanation process, producing the desired 2d smoothly with a good level of enantiocontrol (entry 4). The metalloradical cyclopropanation system was shown to also tolerate the presence of halogen atoms in the substrates, as exemplified for the stereoselective formation of brominated bicyclo[3.1.0]hexan-2-one 2e (entry 5). In addition to allyl α-diazoacetates with aryl substituents, the Co(II)-based catalytic system could be applied to heteroaryl-containing α-diazoacetates, as demonstrated with the intramolecular cyclopropanation of (E)-3-(furan-2-yl)allyl α-diazoacetate (1f), which was transformed into 6-(furan-2-yl)-3-oxabicyclo[3.1.0]hexan-2-one (2f) in 77% yield with complete diastereocontrol and 63% ee (entry 6). Furthermore, even the sterically demanding tri-substituted olefin-based allyl α-diazoacetates were found to be effective substrates for the intramolecular cyclopropanation via Co(II)-based MRC. For example, the reactions of allyl α-diazoacetates 1g and 1h could be effectively catalyzed by [Co(P1)] to form the corresponding 6,6-disubstituted 3-oxabicyclo[3.1.0]hexan-2-one products 2g and 2h, respectively, in good yields and stereoselectivities (entries 7 and 8).
a Reactions were carried out in a one-portion protocol using 2 mol % catalyst under N2 for 24 h with [1] = 0.20 M. b Isolated yields. c The trans/cis ratio was determined by 1H NMR. d Enantiomeric excess of the major diastereomer was determined by chiral HPLC. e Reaction was carried out at 40 °C. Reaction under room temperature resulted in 35% yield with 90% ee. |
---|
(1R,5S,6S)-6-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one ( 2a ) was obtained using the general procedure in 70% yield (24.3 mg). [α]20D = 61 (c = 2.05, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.31–7.21 (m, 3H), 7.05–7.04 (m, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.39 (d, J = 9.6 Hz, 1H), 2.53–2.49 (m, 1H), 2.33–2.30 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 174.9, 137.1, 128.7, 127.1, 125.9, 69.69, 29.34, 27.36, 26.12. IR (neat, cm−1): 2923 (C–H), 2852 (C–H), 1740 (CO). HRMS (ESI): calcd for C11H11O2 ([M + H]+) m/z 175.0759, found 175.0765. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 34 min; temperature increased 5.0 °C min−1 to a final temperature of 180 °C): 72% ee; 19.7 min (major) 21.8 min (minor).
6-(p-Tolyl)-3-oxabicyclo[3.1.0]hexan-2-one ( 2b ) was obtained using the general procedure in 95% yield (35.9 mg). [α]20D = 66 (c = 3.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.11 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.40 (d, J = 9.6 Hz, 1H), 2.51–2.48 (m, 1H), 2.32 (s, 3H), 2.30–2.29 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 175.1, 136.8, 134.1, 129.3, 125.8, 69.69, 29.12, 27.24, 25.94, 20.93. IR (neat, cm−1): 2979 (C–H), 2848 (C–H), 1766 (CO). HRMS (ESI): calcd for C12H13O2 ([M + H]+) m/z 189.0915, found 189.0919. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C; isothermal for 30 min): 84% ee; 30.6 min (major) 33.2 min (minor).
6-(o-Tolyl)-3-oxabicyclo[3.1.0]hexan-2-one ( 2c ) was obtained using the general procedure in 94% yield (35.2 mg). [α]20D = 24 (c = 1.16, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.19–7.13 (m, 3H), 6.95 (d, J = 6.8 Hz, 1H), 4.48 (dd, J = 4.8, 9.6 Hz, 1H), 4.43 (d, J = 9.6 Hz, 1H), 2.58–2.54 (m, 1H), 2.43 (s, 3H), 2.35–2.33 (m, 1H), 2.31–2.29 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 175.2, 137.5, 134.7, 130.2, 127.3, 126.1, 125.4, 69.68, 27.62, 25.99, 24.59, 19.55. IR (neat, cm−1): 2979 (C–H), 2904 (C–H), 1766 (CO). HRMS (ESI): calcd for C12H13O2 ([M + H]+) m/z 189.0915, found 189.0905. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C; isothermal for 30 min): 78% ee; 25.0 min (major) and 26.9 min (minor).
6-(4-Methoxyphenyl)-3-oxabicyclo[3.1.0]hexan-2-one ( 2d ) was obtained using the general procedure in 88% yield (36.1 mg). [α]20D = 62 (c = 0.72, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.00 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.4, 9.6 Hz, 1H), 4.39 (d, J = 9.6 Hz, 1H), 3.81 (s, 3H), 2.49–2.46 (m, 1H), 2.29–2.25 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 175.1, 158.7, 129.0, 127.1, 114.1, 69.69, 55.29, 28.91, 27.18, 25.72. IR (neat, cm−1): 2927 (C–H), 2851 (C–H), 1760 (CO). HRMS (ESI): calcd for C12H13O3 ([M + H]+) m/z 205.0864, found 205.0868. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C; isothermal for 30 min): 70% ee; 66.1 min (major) and 67.8 min (minor).
6-(4-Bromophenyl)-3-oxabicyclo[3.1.0]hexan-2-one ( 2e ) was obtained using the general procedure in 84% yield (42.3 mg). [α]20D = 54 (c = 0.70, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.42 (d, J = 8.4 Hz, 2H), 6.93 (d, J = 8.4 Hz, 2H), 4.45 (dd, J = 4.8, 9.6 Hz, 1H), 4.40 (d, J = 9.6 Hz, 1H), 2.52–2.48 (m, 1H), 2.31–2.26 (m, 2H). 13C NMR (100 MHz, CDCl3): δ 174.5, 136.2, 131.8, 127.6, 120.9, 69.58, 28.69, 27.23, 26.09. IR (neat, cm−1): 2922 (C–H), 2852 (C–H), 1743 (CO). HRMS (ESI): calcd for C11H10BrO2 ([M + H]+) m/z 252.9864, found 252.9869. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C; isothermal for 30 min): 83% ee; 75.9 min (major) and 79.3 min (minor).
6-(Furan-2-yl)-3-oxabicyclo[3.1.0]hexan-2-one ( 2f ) was obtained using the general procedure in 77% yield (25.3 mg). [α]20D = 85 (c = 0.36, CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.25 (d, J = 1.2 Hz, 1H), 6.29–6.27 (m, 1H), 6.12 (d, J = 3.2 Hz, 1H), 4.42 (dd, J = 4.8, 9.6 Hz, 1H), 4.36 (d, J = 9.6 Hz, 1H), 2.63–2.60 (m, 1H), 2.42–2.40 (m, 1H), 2.34–2.32 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 174.4, 149.9, 141.7, 110.6, 106.3, 69.28, 25.15, 24.03, 22.73. IR (neat, cm−1): 2979 (C–H), 2910 (C–H), 1762 (CO). HRMS (ESI): calcd for C9H9O3 ([M + H]+) m/z 165.0551, found 165.0549. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C): 63% ee; 8.8 min (major) and 9.8 min (minor).
6-Methyl-6-phenyl-3-oxabicyclo[3.1.0]hexan-2-one ( 2g ) was obtained using the general procedure in 86% yield (32.5 mg). [α]20D = 71 (c = 0.46, CHCl3). 1H NMR (400 MHz, CDCl3): 7.33–7.21 (m, 5H), δ 4.51 (dd, J = 5.2, 10.0 Hz, 1H), 4.34 (d, J = 10.0 Hz, 1H), 2.53–2.50 (m, 1H), 2.44–2.43 (m, 1H), 1.46 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 174.4, 143.3, 128.7, 127.2, 127.1, 66.54, 31.02, 30.63, 29.32, 15.59. IR (neat, cm−1): 2980 (C–H), 2902 (C–H), 1762 (CO). HRMS (ESI): Calcd for C12H13O2 ([M + H]+) m/z 189.0916, found 189.0922. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 60 min; temperature increased 4.0 °C min−1 to a final temperature of 180 °C; isothermal for 30 min): 79% ee; 16.9 min (minor) and 18.0 min (major).
6,6-Dimethyl-3-oxabicyclo[3.1.0]hexan-2-one ( 2h ) was obtained using the general procedure in 35% yield (9.0 mg). [α]20D = 67 (c = 0.15, CHCl3). 1H NMR (400 MHz, CDCl3): δ 4.35 (dd, J = 5.6, 10.0 Hz, 1H), 4.15 (d, J = 10.0 Hz, 1H), 2.05–2.02 (m, 1H), 1.95–1.94 (m, 1H), 1.18 (s, 3H), 1.17 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 174.9, 66.52, 30.49, 30.02, 25.20, 14.40. IR (neat, cm−1): 2980 (C–H), 2902 (C–H), 1766 (CO). HRMS (ESI): Calcd for C9H9O3 ([M + H]+) m/z 127.0759, found 127.0748. GC/MS: Chiraldex G-TA (initial temperature: 150 °C; isothermal for 3 min; temperature increased 5.0 °C min−1 to a final temperature of 180 °C; isothermal for 11 min): 90% ee; 20.9 min (minor) and 22.3 min (major).
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c4qo00041b |
This journal is © the Partner Organisations 2014 |